2/23/24 16:18 | 2/22/24 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Levine Mark S. | NY | O | GC | S | -77 | 36.15 | 0 | -2 | -1 | 302 | D | | | | | | | | | | | | | | |
1/29/24 16:12 | 1/26/24 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Levine Mark S. | NY | O | GC | S | -115 | 37.92 | 0 | -3 | -1 | 304 | D | | | | | | | | | | | | | | |
11/24/23 14:41 | 11/22/23 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Levine Mark S. | NY | O | GC | S | -107 | 32.78 | 0 | -3 | -1 | 307 | D | | | | | | | | | | | | | | |
10/27/23 16:04 | 10/25/23 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Levine Mark S. | NY | O | GC | S | -142 | 34.66 | 0 | -4 | -1 | 310 | D | | | | | | | | | | | | | | |
8/25/23 17:05 | 8/24/23 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Levine Mark S. | NY | O | GC | S | -249 | 20.30 | 0 | -12 | -4 | 314 | D | | | | | | | | | | | | | | |
7/27/23 16:33 | 7/26/23 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Levine Mark S. | NY | O | GC | S | -85 | 21.63 | 0 | -4 | -1 | 327 | D | | | | | | | | | | | | | | |
4/26/23 16:08 | 4/25/23 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Levine Mark S. | NY | O | GC | S | -43 | 16.29 | 0 | -3 | -1 | 331 | D | | | | | | | | | | | | | | |
1/27/23 07:20 | 1/26/23 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Levine Mark S. | NY | O | GC | S | -188 | 18.51 | 0 | -10 | -4 | 246 | D | | | | | | | | | | | | | | |
7/20/21 20:45 | 7/19/21 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Levine Mark S. | MA | O | GC | S | -25 | 6.45 | 0 | -4 | -3 | 133 | D | | | | | | | | | | | | | | |
1/7/21 17:52 | 1/5/21 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Levine Mark S. | MA | O | GC | S | -76 | 11.13 | 0 | -7 | -6 | 107 | D | | | | | | | | | | | | | | |
1/7/20 16:35 | 1/3/20 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Levine Mark S. | MA | O | GC | S | 0 | 0.00 | 0 | -4 | -8 | 43 | D | | | | | | | | | | | | | | |
1/4/19 17:12 | 1/3/19 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Levine Mark S. | MA | O | GC | S | -9 | 12.36 | 0 | -1 | -7 | 9 | D | | | | | | | | | | | | | | |
6/5/17 16:33 | 6/1/17 | NERV | Minerva Neurosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Levine Mark S. | MA | O | SVP,GC,S | M.d | 91 | 5.19 | 0 | 18 | | 0 | D | | | | | | | | | | | | | | |
6/5/17 16:33 | 6/1/17 | NERV | Minerva Neurosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Levine Mark S. | MA | O | SVP,GC,S | S.d | -193 | 11.00 | 0 | -18 | -100 | 0 | D | | | | | | | | | | | | | | |
1/6/17 16:28 | 1/4/17 | NERV | Minerva Neurosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Levine Mark S. | MA | O | SVP,GC,S | M.d | 83 | 4.72 | 3 | 18 | | 0 | D | 87 | 114 | 14 | -15 | -11 | -10 | -5 | 3 | 2 | -5 | -9 | -38 | | |
1/6/17 16:28 | 1/4/17 | NERV | Minerva Neurosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Levine Mark S. | MA | O | SVP,GC,S | S.d | -210 | 12.00 | 3 | -18 | -100 | 0 | D | 87 | 114 | 14 | -15 | -11 | -10 | -5 | 3 | 2 | -5 | -9 | -38 | | |